Sandhya Srinivas
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Renal cell carcinoma treatment 6
-
- Venous Thromboembolism Diagnosis and Management 2
- Co-authors
- Robert A Raschke (2 shared papers)Bernard J. Escudier (2 shared papers)Bernice Y. Kwong (2 shared papers)Roberto A. Novoa (2 shared papers)Archibald James Mixson (1 shared paper)Sanford A. Stass (1 shared paper)Dhiren Kumar (1 shared paper)Jinah Kim (1 shared paper)
- Journals
- The Lancet Oncology (2 papers)Journal of Clinical Oncology (2 papers)Molecular Cancer Therapeutics (1 paper)American Journal of Infection Control (1 paper)Journal of General Internal Medicine (1 paper)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Sandhya Srinivas
16 papers receiving 7k citations
Sandhya Srinivas's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 3.3k
- Internal Medicine 446
- Pulmonary and Respiratory Medicine 2.5k
- Cancer Research 249
- Surgery 563
Countries citing papers authored by Sandhya Srinivas
This map shows the geographic impact of Sandhya Srinivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandhya Srinivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandhya Srinivas more than expected).
Fields of papers citing papers by Sandhya Srinivas
This network shows the impact of papers produced by Sandhya Srinivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandhya Srinivas. The network helps show where Sandhya Srinivas may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandhya Srinivas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma Hit paper breakdown → | 2015 | 4852 |
| 2 | The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram Hit paper breakdown → | 1993 | 582 |
| 3 | Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2020 | 408 |
| 4 | 2020 | 251 | |
| 5 | 2017 | 207 | |
| 6 | 2009 | 175 | |
| 7 | Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study Hit paper breakdown → | 2022 | 138 |
| 8 | 1997 | 115 | |
| 9 | 2016 | 114 | |
| 10 | 2012 | 113 | |
| 11 | Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study Hit paper breakdown → | 2024 | 99 |
| 12 | 2019 | 80 | |
| 13 | 2020 | 32 | |
| 14 | 2022 | 24 | |
| 15 | 1993 | 17 | |
| 16 | A Phase 2 study of the dual MET/VEGFR2 inhibitor XL880 in patients (pts) with papillary renal carcinoma (PRC). | 2007 | 7 |
| 17 | 2017 | 1 |
About Sandhya Srinivas
Sandhya Srinivas is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine, Oncology, Emergency Medical Services and Dermatology, having authored 17 papers that have together received 7.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), RNA Interference and Gene Delivery (1 paper), Chemotherapy-related skin toxicity (1 paper), Central Venous Catheters and Hemodialysis (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (3.3k citations), Internal Medicine (446 citations), Pulmonary and Respiratory Medicine (2.5k citations), Cancer Research (249 citations) and Surgery (563 citations). Sandhya Srinivas has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Robert A Raschke, Bernard J. Escudier, Bernice Y. Kwong, Roberto A. Novoa, Archibald James Mixson, Sanford A. Stass, Dhiren Kumar, Jinah Kim, Min Xu and Louis J. DeTolla. Their work appears in journals such as The Lancet Oncology, Journal of Clinical Oncology, Molecular Cancer Therapeutics, American Journal of Infection Control and Journal of General Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.